Release Date: Apr 1, 2018
Valid Through: Apr 1, 2020. This course will be updated or expired on this date
Successful Completion: Complete entire module, complete the exam with a passing score of 80% or better, and complete the evaluation form
Estimated Time to Complete Activity: 60 minutes
CEUs: See Continuing Education section
Media: Internet. Available 24/7 365 Online. See requirements below
Understand the purpose of HIPAA legislation Explain the changes implemented to HIPAA by the Omnibus Final Rule Identify the key elements of the Privacy Rule, Security Rule, and Enforcement Rule Explain the process for Breach Notification Understand the Unique Identifiers and Transaction and Code Set Rules Be aware of how to apply these rules to his/her functions as a Business Associate
This course is designed to provide a comprehensive look at HIPAA legislation as it applies to Business Associates, such as those involved in claims processing, billing and data analysis. Recent updates to HIPAA as a result of the HITECH Act and the Omnibus Final Rule greatly increased Business Associates’ liabilities related to HIPAA compliance. This course covers the Privacy Rule, Security Rule, Breach Notification Rule, and Enforcement Rule in detail, while highlighting what is important to a Business Associate, such as the expanded definition of what constitutes a Business Associate and what should be included in Business Associate Agreements. In order to be prepared for potential audits, to ensure privacy of protected health information and to avoid potential civil and criminal penalties, it is imperative that Business Associates have a solid understanding of this complex legislation.
HIPAA Exams, Inc. requires that the faculty participating in any activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this activity. HIPAA Exams, Inc. also requires participating faculty to disclose when unapproved/unlabeled uses of a product are discussed in a activity.
This activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products.
The content for this activity was developed independently of the commercial support. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ANCC Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
|Bundle||Price Per Person|
|100 +||Call for $|
Toll Free: 1.888-362-2288
8 AM - 4 PM MST (M-F)